Ascendiant Capital Maintains Buy on Aemetis, Lowers Price Target to $18

Benzinga · 1d ago
Ascendiant Capital analyst Edward Woo maintains Aemetis (NASDAQ:AMTX) with a Buy and lowers the price target from $20 to $18.